MORE►
Concord Health Partners
Dr. Ruben Amarasingham, founder and CEO of Pieces
Dallas’ Pieces Technologies Gets $2M from National Cancer Institute to Advance Conversational AI for Cancer Patients
by Lance Murray | Oct 30, 2024
With the NCI funding—which follows Piece's $25 million growth financing round announced in September—Pieces will partner with Cleveland-based MetroHealth to deploy a new conversational AI agent for cancer patients called "PiecesChat."
by Lance Murray |
Sep 10, 2024
"Our mission is to help those who help others," says Pieces Technologies CEO Dr. Ruben Amarasingham. With $25M in growth funding, Dallas-based Pieces is gearing up to transform hospital care with AI that streamlines clinical workflows and eases the load on care teams.
MORE►
by Kevin Cummings |
Jun 8, 2022
Irving-based Pieces, a health care-focused AI company, is teaming up with a Philadelphia firm to accelerate patient identification for a National Cancer Institute colorectal cancer study. Nearly 10,000 participants will be needed across the U.S.
Pieces will use its analytics platform—which combines AI with natural language processing, to “read” through hundreds of thousands of electronic colonoscopy notes and records—to quickly identify patients that meet the study’s criteria.
MORE►
by Lance Murray |
Jan 7, 2020
The funding will accelerate the national distribution of Pieces’ clinical analytics engine and social determinants of health platform.
MORE►
